Here’s what you need to know:
1. Patients of NueHealth’s provider networks will have access to three screening types, including ColonSentry, a screening test that provides early risk stratification for colorectal cancer.
2. ColonSentry utilizes a blood test, which measures the expression of gene biomarkers that are early warning signs of colorectal cancer.
3. The tests will be processed by GeneNews at a clinical reference lab in Richmond, Va.
More articles on gastroenterology and endoscopy:
Vitamin A metabolite may suppress colorectal cancer: 5 study insights
Hannibal Regional Medical Group adds Dr. Ashraf Almashhrawi: 5 things to know
Migraines associated with GI disorders: 5 study insights
